Compare BBSI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBSI | ARQT |
|---|---|---|
| Founded | 1965 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 887.4M | 3.3B |
| IPO Year | 1993 | 2020 |
| Metric | BBSI | ARQT |
|---|---|---|
| Price | $36.28 | $28.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $45.50 | $24.83 |
| AVG Volume (30 Days) | 156.5K | ★ 1.8M |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | ★ 10.03 | N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $1,223,992,000.00 | $317,929,000.00 |
| Revenue This Year | $10.70 | $85.51 |
| Revenue Next Year | $7.58 | $30.74 |
| P/E Ratio | $17.39 | ★ N/A |
| Revenue Growth | 9.64 | ★ 129.21 |
| 52 Week Low | $33.01 | $11.13 |
| 52 Week High | $49.65 | $31.77 |
| Indicator | BBSI | ARQT |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 52.58 |
| Support Level | $35.71 | $27.71 |
| Resistance Level | $37.47 | $30.26 |
| Average True Range (ATR) | 0.74 | 1.06 |
| MACD | 0.11 | -0.24 |
| Stochastic Oscillator | 29.74 | 49.91 |
Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.